Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors
Title:
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors
Author:
Någård, Mats Ah-See, Mei-Lin Strauss, James Wise-Draper, Trisha Safran, Howard P. Nadeau, Laura Edenfield, William J. Lewis, Lionel D. Ottesen, Lone H. Li, Yan Mugundu, Ganesh M.